Chimeric antigen receptor therapy for T-cell acute lymphoblastic leukemia: finally catching up with B-cell leukemia?

Haematologica. 2024 Jun 1;109(6):1631-1633. doi: 10.3324/haematol.2024.284982.

Authors

Ofrat Beyar-Katz¹, Jacob M Rowe²

Affiliations

¹ Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa; The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa. [email protected].
² Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa; The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa; Shaare Zedek Medical Center, Jerusalem.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Humans
Immunotherapy, Adoptive* / adverse effects
Immunotherapy, Adoptive* / methods
Leukemia, B-Cell / therapy
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / therapy
Receptors, Chimeric Antigen* / immunology

Substances

Receptors, Chimeric Antigen